Annual EBIT
-$116.22 M
-$96.43 M-487.11%
31 December 2023
Summary:
Repare Therapeutics annual earnings before interest & taxes is currently -$116.22 million, with the most recent change of -$96.43 million (-487.11%) on 31 December 2023. During the last 3 years, it has fallen by -$61.92 million (-114.03%). RPTX annual EBIT is now -1782.17% below its all-time high of -$6.07 million.RPTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$34.84 M
+$2.47 M+6.63%
30 September 2024
Summary:
Repare Therapeutics quarterly earnings before interest & taxes is currently -$34.84 million, with the most recent change of +$2.47 million (+6.63%) on 30 September 2024. Over the past year, it has increased by +$3.57 million (+9.30%). RPTX quarterly EBIT is now -147.47% below its all-time high of $73.40 million, reached on 30 September 2022.RPTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$92.22 M
+$3.57 M+3.73%
30 September 2024
Summary:
Repare Therapeutics TTM earnings before interest & taxes is currently -$92.22 million, with the most recent change of +$3.57 million (+3.73%) on 30 September 2024. Over the past year, it has increased by +$12.77 million (+12.17%). RPTX TTM EBIT is now -1450.54% below its all-time high of $6.83 million, reached on 30 June 2023.RPTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPTX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -487.1% | +9.3% | +12.2% |
| 3 y3 years | -114.0% | -10.0% | +4.9% |
| 5 y5 years | -806.6% | -407.4% | -426.0% |
RPTX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -487.1% | at low | -147.5% | +10.0% | -1450.5% | +31.2% |
| 5 y | 5 years | -806.6% | at low | -147.5% | +10.0% | -1450.5% | +31.2% |
| alltime | all time | -1782.2% | at low | -147.5% | +10.0% | -1450.5% | +31.2% |
Repare Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$34.84 M(-6.6%) | -$92.22 M(-3.7%) |
| June 2024 | - | -$37.32 M(-445.0%) | -$95.79 M(+35.4%) |
| Mar 2024 | - | $10.82 M(-135.0%) | -$70.73 M(-39.1%) |
| Dec 2023 | -$116.22 M(+487.1%) | -$30.87 M(-19.7%) | -$116.22 M(+10.7%) |
| Sept 2023 | - | -$38.42 M(+213.4%) | -$104.99 M(-1637.6%) |
| June 2023 | - | -$12.26 M(-64.7%) | $6.83 M(-134.8%) |
| Mar 2023 | - | -$34.68 M(+76.7%) | -$19.65 M(-0.7%) |
| Dec 2022 | -$19.80 M(-81.8%) | -$19.63 M(-126.7%) | -$19.80 M(-31.5%) |
| Sept 2022 | - | $73.40 M(-289.5%) | -$28.90 M(-78.4%) |
| June 2022 | - | -$38.73 M(+11.2%) | -$133.98 M(+9.9%) |
| Mar 2022 | - | -$34.83 M(+21.2%) | -$121.91 M(+12.2%) |
| Dec 2021 | -$108.66 M | -$28.73 M(-9.3%) | -$108.66 M(+12.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$31.68 M(+18.8%) | -$97.00 M(+22.2%) |
| June 2021 | - | -$26.67 M(+23.6%) | -$79.41 M(+22.0%) |
| Mar 2021 | - | -$21.58 M(+26.4%) | -$65.07 M(+19.8%) |
| Dec 2020 | -$54.30 M(+105.9%) | -$17.08 M(+21.2%) | -$54.30 M(+17.9%) |
| Sept 2020 | - | -$14.09 M(+14.3%) | -$46.07 M(+18.6%) |
| June 2020 | - | -$12.32 M(+13.9%) | -$38.85 M(+19.9%) |
| Mar 2020 | - | -$10.81 M(+22.3%) | -$32.41 M(+22.9%) |
| Dec 2019 | -$26.38 M(+105.7%) | -$8.85 M(+28.8%) | -$26.38 M(+50.5%) |
| Sept 2019 | - | -$6.87 M(+16.7%) | -$17.53 M(+64.4%) |
| June 2019 | - | -$5.88 M(+23.1%) | -$10.66 M(+123.1%) |
| Mar 2019 | - | -$4.78 M | -$4.78 M |
| Dec 2018 | -$12.82 M(+107.6%) | - | - |
| Dec 2017 | -$6.17 M | - | - |
FAQ
- What is Repare Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Repare Therapeutics?
- What is Repare Therapeutics annual EBIT year-on-year change?
- What is Repare Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Repare Therapeutics?
- What is Repare Therapeutics quarterly EBIT year-on-year change?
- What is Repare Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Repare Therapeutics?
- What is Repare Therapeutics TTM EBIT year-on-year change?
What is Repare Therapeutics annual earnings before interest & taxes?
The current annual EBIT of RPTX is -$116.22 M
What is the all time high annual EBIT for Repare Therapeutics?
Repare Therapeutics all-time high annual earnings before interest & taxes is -$6.07 M
What is Repare Therapeutics annual EBIT year-on-year change?
Over the past year, RPTX annual earnings before interest & taxes has changed by -$96.43 M (-487.11%)
What is Repare Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of RPTX is -$34.84 M
What is the all time high quarterly EBIT for Repare Therapeutics?
Repare Therapeutics all-time high quarterly earnings before interest & taxes is $73.40 M
What is Repare Therapeutics quarterly EBIT year-on-year change?
Over the past year, RPTX quarterly earnings before interest & taxes has changed by +$3.57 M (+9.30%)
What is Repare Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of RPTX is -$92.22 M
What is the all time high TTM EBIT for Repare Therapeutics?
Repare Therapeutics all-time high TTM earnings before interest & taxes is $6.83 M
What is Repare Therapeutics TTM EBIT year-on-year change?
Over the past year, RPTX TTM earnings before interest & taxes has changed by +$12.77 M (+12.17%)